Article
Chemogenomic profiling of the cellular effects associated with histone H3 acetylation impairment by a quinoline-derived compound.
Genomics - 1 Nov 2010
Ruotolo Roberta, Tosi Federica, Vernarecci Stefano, Ballario Paola, Mai Antonello, Filetici Patrizia, Ottonello Simone
Abstract excerpt
We report the results of a chemogenomic profiling aimed to explore the mode of action of a quinolic analogue of the p300 histone acetyltransferase (HAT) inhibitor anacardic acid, named MC1626. This compound reduced histone H3 acetylation in a dose-dependent manner and the HATs Gcn5 and Rtt109, which specifically target H3 lysines, were the only ones that caused chemical-genetic synthetic sickness with MC1626 when...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
